{"id":998,"date":"2020-01-14T17:36:42","date_gmt":"2020-01-14T16:36:42","guid":{"rendered":"https:\/\/dose-innova.ccoo.cat\/?p=998"},"modified":"2020-01-14T17:36:42","modified_gmt":"2020-01-14T16:36:42","slug":"venda-generics","status":"publish","type":"post","link":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/venda-generics\/","title":{"rendered":"Venda Gen\u00e8rics"},"content":{"rendered":"<p><span style=\"font-weight: 400\">(Nota publicada el passat 23 de desembre de 2019)<\/span><\/p>\n<p><span style=\"font-weight: 400\">Aquest mat\u00ed la Direcci\u00f3 de Gen\u00e8rics ens ha comunicat que s&#8217;ha tancat l&#8217;acord de venda amb el grup industrial japon\u00e8s TowaPharmaceuticals. que passar\u00e0 a ser propietari de la totalitat del negoci de Gen\u00e8rics (DoseInnova, Pensa i Breckenridge).<\/span><\/p>\n<p><span style=\"font-weight: 400\">La Direcci\u00f3 de Gen\u00e8rics ens ha traslladat que la seva intenci\u00f3 era tancar l&#8217;acord uns dies enrere, per a comunicar-lo a la plantilla durant el transcurs de l&#8217;\u00faltim dia laboral de l&#8217;any, per\u00f2 per una s\u00e8rie de problemes legals no va poder ser aix\u00ed.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Segons ens ha explicat la Direcci\u00f3 de Gen\u00e8rics, Towa est\u00e0 alineada amb Esteve en dos aspectes fonamentals:<\/span><\/p>\n<ul>\n<li><span style=\"font-weight: 400\">La seva cultura, en tractar-se d&#8217;una empresa familiar.<\/span><\/li>\n<li><span style=\"font-weight: 400\">La seva m\u00e0xima exig\u00e8ncia en mat\u00e8ria de qualitat.&nbsp;<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400\">Aquestes similituds entre Towa i Esteve, garanteixen que l&#8217;operaci\u00f3 de venda respectar\u00e0 tots els lloc de treball, aix\u00ed com els actuals est\u00e0ndards de qualitat, tot aix\u00f2 sempre segons la Direcci\u00f3 de Gen\u00e8rics,<\/span><\/p>\n<p><span style=\"font-weight: 400\">A la fi de Gener la direcci\u00f3 de Towa vindr\u00e0 a Barcelona a realitzar un tour de presentacions. Com RLT esperem poder tenir una primera presa de contacte en aquest moment.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Finalment, la Direcci\u00f3 de Gen\u00e8rics ens ha explicat que estan treballant per a aconseguir nous contractes, que de tancar-se suposaran un increment del volum productiu de la planta. De concretar-se aquest increment, si les noves instal\u00b7lacions de f\u00e0brica encara no estan en funcionament, \u00e9s probable que s&#8217;hagin d&#8217;aplicar mesures de flexibilitat laboral.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p>Martorelles, 23 de desembre de 2019.    \t<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Nota publicada el passat 23 de desembre de 2019) Aquest mat\u00ed la Direcci\u00f3 de Gen\u00e8rics ens ha comunicat que s&#8217;ha tancat l&#8217;acord de venda amb el grup industrial japon\u00e8s TowaPharmaceuticals. &#8230; <a title=\"Venda Gen\u00e8rics\" class=\"read-more\" href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/venda-generics\/\" aria-label=\"Leer m\u00e1s sobre Venda Gen\u00e8rics\">Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":59,"featured_media":694,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[],"class_list":["post-998","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notesinformatives_ca","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/comments?post=998"}],"version-history":[{"count":0,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/998\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media\/694"}],"wp:attachment":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media?parent=998"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/categories?post=998"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/tags?post=998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}